Patents for C12P 21 - Preparation of peptides or proteins (112,499)
10/2007
10/31/2007EP1414857A4 Factor viii separation
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1183346B1 Method for generating split, non-transferable genes that are able to express an active protein product
10/31/2007EP1177312B1 Human gil-19/ae289 proteins and polynucleotides encoding same
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP0998576B1 Method for producing a recombinant bovine adenovirus vector
10/31/2007EP0871645B1 Modulators of the function of fas/apo1 receptors
10/31/2007EP0851030B9 PROTEIN SPECIFIC TO HUMAN Th2, GENE (B19) ENCODING THE SAME, AND TRANSFORMANT, RECOMBINANT VECTOR AND MONOCLONAL ANTIBODY RELATING THERETO
10/31/2007DE19515310B4 Isoelastische Hüftendoprothese Isoelastic hip replacement
10/31/2007CN101065493A Enzymatic reactions in the presence of keto acids
10/31/2007CN101065477A Process for producing substances
10/31/2007CN101065402A Process for obtaining antibodies
10/31/2007CN101065136A Prion protein binding materials and methods of use
10/31/2007CN101065096A Duffy antigen receptor for chemokines and use thereof
10/31/2007CN101063162A Method for preparing functional protein peptide
10/31/2007CN101063161A Coproduction technique for collagen and chondroitin sulfate
10/31/2007CN101063141A Moraxella(branhamella) catarrhalis antigens
10/31/2007CN101063101A Cattle lactoferrin engineering bacterium and preparation method for antibiotic peptide cattle lactoferrin
10/31/2007CN101062953A Immune toxin and preparation method and usage
10/31/2007CN101062949A Recombinant anti human IgE monoclonal antibody and preparation method and usage thereof
10/31/2007CN101062948A Monomer quick-effective insulin and preparation method and usage thereof
10/31/2007CN101062405A Medicine for animals for treating and preventing avian influenza
10/31/2007CN100345971C Recombinant human stem cell factor prokaryote expression vector, engineering bacteria and its preparation method
10/31/2007CN100345970C Receptor based antagonists and mehtods of making and using
10/30/2007US7288637 Single chain antibody against mutant p53
10/30/2007US7288635 Antibodies to a testis-specific differentiation-regulatory factor
10/30/2007US7288634 Isolated antibodies immunoreactive with synthetic peptides used to detect rheumatoid arthritis
10/30/2007US7288633 To induce the activities of B cells and T cells in therapy of immune deficiency disorders, viral infections, and bacterial infections
10/30/2007US7288631 G-coupled receptor showing selective affinity for ATP
10/30/2007US7288628 PRO20088 polypeptides
10/30/2007US7288627 PRO polypeptides; fusion proteins; immunoglobulins; cytokines; for releasing tumor necrosis factor from blood; for modulating uptake of glucose by skeletal muscle cells; for stimulating release of proteoglycans from cartilage
10/30/2007US7288626 Used as pharmaceuticals, diagnostics, biosensors and bioreactors
10/30/2007US7288402 Rhodococcus polynucleotide cluster that contains 4 nucleotide sequences that encode 2 polypeptides having nitrile hydratase activity, an auxiliary protein P15K that activates this enzyme, and a cobalt transporter
10/30/2007US7288395 ACC gene
10/30/2007US7288392 Vectors, host cells, and recombinant methods for making and using the novel molecules
10/30/2007US7288391 Expression of spider silk proteins in higher plants
10/30/2007US7288390 Anti-dual integrin antibodies, compositions, methods and uses
10/30/2007US7288389 DNA codes for proteins or polypeptides having hydrolase enzyme activity, used for peptide synthesis; biocatalysts; genetic engineering; biosynthesis
10/30/2007US7288388 Peptide-forming enzyme gene, peptide-forming enzyme, and peptide producing method
10/30/2007US7288385 Identifying a compound that modulates the insulin/IGF-I pathway by contacting a that expresses a Smek protein with a compound, and comparing the activity of the Smek protein after contacting and the activity of the Smek protein in the absence of the compound; the compounds increase stress tolerance
10/30/2007US7288382 Subject methods involve introduction of cysteine residues, which serve as probes for physical analysis, into a protein by translational misincorporation in vivo
10/30/2007US7288381 Group 2 allergen specific IgE-Fabs and use thereof
10/30/2007US7288375 Introducing one or more mutations into a template double-stranded polynucleotide via hybridization, replication and amplification of random genomic double stranded and heterozygous oligonucleotides sequences; genomics and directed evolution
10/30/2007US7288255 Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
10/30/2007US7288252 Administering antigen , or antagonist antibody; binding; antiproliferative agents; controlling cell differentiation
10/30/2007US7288251 Antibodies to CD40
10/30/2007CA2272356C Soluble polypeptides
10/30/2007CA2150378C Mammalian muscle nad:arginine adp-ribosyltransferase
10/30/2007CA2145397C Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
10/30/2007CA2142007C Immunomodulatory peptides
10/30/2007CA1341560C Recombinant dna-derived bordetella toxin subunit analogs
10/25/2007WO2007121100A2 Compositions and methods for producing fermentation products and residuals
10/25/2007WO2007120932A2 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms
10/25/2007WO2007119808A1 Fusion partner cells
10/25/2007WO2007119796A1 Mutant polypeptide having effector function
10/25/2007WO2007119774A1 Taurine transporter gene
10/25/2007WO2007119518A1 Anti-methylated dna antibody and method for production thereof
10/25/2007WO2007062063A3 Recombinant viral compositions and uses thereof
10/25/2007WO2007053731A3 Expression of soluble factor viii proteins in bacteria
10/25/2007WO2007018482A3 Polypeptides for inducing a protective immune response against staphylococcus aureus
10/25/2007WO2005034877A3 G-csf transferrin fusion proteins
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070249814 Transcriptional regulatory factor
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249538 tumor necrosis factor (TNF) antagonists and corresponding nucleic acids; inflammatory diseases; the proteins lack exon 7 and which can bind TNF and can act as a TNF antagonist
10/25/2007US20070249533 Il-17a and il-17f antagonists and methods of using the same
10/25/2007US20070249521 polypeptide having antimicrobial activity, having an amino acid sequence selected from e.g. Arg Arg Arg Pro Pro Arg Leu Pro Arg Pro Phe Pro; Phe Arg Pro Pro Pro Arg Pro Arg Pro Leu Pro Val; detergents, animal feed
10/25/2007US20070249032 Flavivirus vaccine
10/25/2007US20070249022 Osteoporosis; transforming growth factors; pyrogen-free
10/25/2007US20070249021 Deglycosylated and Desialidated Long Pentraxin Ptx3
10/25/2007US20070249020 Cytokine zcytor17 ligand polypeptides and polynucleotides
10/25/2007US20070249019 Purification processes for isolating purified vesicular stomatitis virus from cell culture
10/25/2007US20070249016 Method for Gene Amplification
10/25/2007US20070249015 Method of isolation and purification of trypsin from pronase protease and use thereof
10/25/2007US20070249014 Labeling and detection of post translationally modified proteins
10/25/2007US20070248995 Molecules
10/25/2007US20070248972 Page-4, an X-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
10/25/2007US20070248962 Compositions and methods for human metapneumovirus monoclonal antibodies
10/25/2007US20070248679 Vaccine
10/25/2007US20070248626 Recombinant toxin fragments
10/25/2007US20070248616 Canine Respiratory Coronavirus (Crcv) Spike Protein, Polymerase and Hemagglutinin/Esterase
10/25/2007US20070248615 T helper cell epitopes
10/25/2007US20070248613 Human Antibodies Interacting with Hiv Gp41
10/25/2007US20070248608 Monoclonal Antibodies to Progastrin
10/25/2007US20070248604 Inhibits fibroblast growth factor (FGF); used to treat a tumor, a cancer, and/or a cell proliferative disorder
10/25/2007US20070248603 Immunoglobulin fusion with enhanced affinity for Fc gamma RIIa; tissue targeted therapy; immunotherapy; directed protein evolution
10/25/2007US20070248602 Fc Variants Having Increased Affinity for FcyRllc
10/25/2007US20070248598 Recombinant anti-VLA4 antibody molecules
10/25/2007US20070248593 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods
10/25/2007US20070248583 Novel Strains Belonging to the Genus Paenibacillus and Method of Controlling Plant Disease by Using These Strains or Culture Thereof
10/25/2007US20070248573 Chimeric Bacteriophages, Chimeric Phage-Like Particles, and Chimeric Phage Ghost Particles, Methods for Their Production and Use
10/25/2007US20070248539 AgRM2 antigen
10/25/2007CA2649325A1 Kits and methods for generating 5' capped rna
10/25/2007CA2649148A1 Taurine transporter gene
10/25/2007CA2648934A1 Compositions and methods for producing fermentation products and residuals
10/25/2007CA2646253A1 Method for cloning and expression of nrui restriction endonuclease
10/25/2007CA2636424A1 Immunostimulatory combinations of tnfrsf, tlr, nlr, rhr, purinergic receptor, and cytokine receptor agonists for vaccines and tumor immunotherapy
10/24/2007EP1847605A2 Methods for producing members of specific binding pairs
10/24/2007EP1847602A1 STABILIZED HUMAN IgG1 AND IgG3 ANTIBODIES
10/24/2007EP1847549A2 Papillomavirus polyprotein constructs